Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Oncotarget - 29 Nov 2016

Zhang Yue-Lun, Yuan Jin-Qiu, Wang Kai-Feng, Fu Xiao-Hong, Han Xiao-Ran, Threapleton Diane, Yang Zu-Yao, Mao Chen, Tang Jin-Ling

Abstract excerpt

OBJECTIVES: Estimate the epidermal growth factor receptor (EGFR) mutation prevalence in all non-small cell lung cancer (NSCLC) patients and patient subgroups. RESULTS: A total of 456 studies were included, reporting 30,466 patients with EGFR mutation among 115,815 NSCLC patients. The overall pooled prevalence for EGFR mutations was 32.3% (95% CI 30.9% to 33.7%), ranging from 38.4% (95% CI: 36.5% to 40.3%) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Europe

Share to Lung Neoplasms

Share to Mutation Rate

Share to Prevalence

Share to Smoking

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 27738317
DOI: 10.18632/oncotarget.12587
PMCID: PMC5346692

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.PMID 27738317Read ↗

EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence and Clinical Profile of EGFR Mutation In Non- Small-Cell Lung Carcinoma Patients in Southwest China.Semantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.Semantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

Patients with Non-small Cell Lung Cancer Analyzed for EGFR: Adherence to Guidelines, Prevalence and Outcome.Semantic proximity Read ↗

EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China.Semantic proximity Read ↗

Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis.Semantic proximity Read ↗

EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience.Semantic proximity Read ↗

Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population.Semantic proximity Read ↗

Germline EGFR mutations in lung cancer (Review)Semantic proximity Read ↗

Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study.Semantic proximity Read ↗

The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Cancer Referred to the Lung Diseases Hospital; A Cross Sectional StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.